Growth Metrics

Medinotec (MDNC) Receivables Refunds (2023)

Medinotec posted quarterly Receivables Refunds of $60794.0 for Q4 2023, down 52.05% on a QoQ basis from $126798.0 in Q3 2023.

Medinotec (MDNC) has 1 years of Receivables Refunds data on file, last reported at $60794.0 in Q4 2023.

  • For the quarter ending Q4 2023, Receivables Refunds changed N/A year-over-year to $60794.0; the trailing twelve-month figure through Nov 2023 stood at $60794.0 (changed N/A YoY), and the FY2023 full-year result was $166643.0, changed N/A from the prior year.
  • Receivables Refunds for Q4 2023 stood at $60794.0, down from $126798.0 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $166643.0 in Q1 2023 and bottomed at $60794.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Refund Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 52.68 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Medinotec - - 854,557.00 -

Historic Data

Download Data 🔒
DateValue
Nov 30, 2023 60,794.00
Aug 31, 2023 126,798.00
Feb 28, 2023 166,643.00